Unlocking bladder cancer

The diagnostics, treatment and five-year survival rates for bladder cancer are largely unchanged since the 1990s. Research into cancer genomics, risk factors and immune therapies could hold the key to progress against this malignant disease.

Download a PDF of the graphic

Layers of risk

Most cases of bladder cancer occur in the cells of the bladder’s innermost lining, the urothelium. In most patients, the cancer has not spread far. These ‘non-muscle-invasive’ tumours are easier to treat and much less lethal than tumours that have grown into the muscle wall or beyond.


Mohamed Ashour

Bladder-cancer diagnoses

Most cases of bladder cancer are the urothelial type. The less-common types are: squamous cell carcinoma, adenocarcinoma, small-cell carcinoma, and sarcoma.

No comfort for old men

Men are about three to four times more likely than women to get bladder cancer, but women are typically diagnosed with more-advanced cancer and have a worse prognosis. Worldwide, bladder cancer is the ninth-most-common cancer and the thirteenth deadliest. But in more-developed countries (below), it poses a bigger threat than many other cancers because fewer new treatment and prevention options have been developed.

Survival and recurrence

Survival unchanged

Unlike many other cancers, there has been no improvement in survival rates for bladder cancer for three decades.


After surgery, people with bladder cancer should have regular cystoscopies (typically every three months for the first year or two, and then every six months) to see if the cancer returns, as well as imaging and urine tests.


1. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012; available at http://go.nature.com/2znpnyy

2. Ploussard, G. et al. Eur. Urol. 66, 120–137 (2014).

3. NIH Surveillance, Epidemiology and End Results Program; available at http://go.nature.com/2yk45st


Mohamed Ashour

Author information



Related links

Related links

Related links in Nature Research

Characteristics and clinical significance of histological variants of bladder cancer

Bladder cancer

The evolving genomic landscape of urothelial carcinoma

The gender difference and mortality-to-incidence ratio relate to health care disparities in bladder cancer: National estimates from 33 countries

Nature Outlook: Kidney cancer

A community map of cancer immunity

Related external links

US NIH Bladder cancer statistics

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Berdik, C. Unlocking bladder cancer. Nature 551, S34–S35 (2017). https://doi.org/10.1038/551S34a

Download citation

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.